Journal ArticleDOI
EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum
Cornelis J.H. van de Velde,Petra G. Boelens,Josep M. Borràs,Jan Willem Coebergh,Andrés Cervantes,Lennart Blomqvist,Regina G. H. Beets-Tan,Colette B.M. van den Broek,Gina Brown,Eric Van Cutsem,Eloy Espin,Karin Haustermans,Bengt Glimelius,Lene Hjerrild Iversen,J. Han van Krieken,Corrie A.M. Marijnen,Geoffrey Henning,Jola Gore-Booth,E. Meldolesi,Pawel Mroczkowski,Iris D. Nagtegaal,Peter Naredi,H. Ortiz,Lars Påhlman,Philip Quirke,Claus Rödel,Arnaud Roth,Harm J. T. Rutten,Hans J. Schmoll,J. J. Smith,Pieter J. Tanis,Claire Taylor,A. Wibe,Theo Wiggers,Maria Antonietta Gambacorta,Cynthia Aristei,Vincenzo Valentini +36 more
Reads0
Chats0
TLDR
The first multidisciplinary consensus conference about cancer of the colon and rectum was held in December 2012 as mentioned in this paper, where the expert panel consisted of representatives of European scientific organisations involved in cancer care of patients with colon and Rectal cancer and representatives of national colorectal registries.About:
This article is published in European Journal of Cancer.The article was published on 2014-01-01. It has received 348 citations till now. The article focuses on the topics: Oncology nursing.read more
Citations
More filters
Journal ArticleDOI
Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
Alessandro Lugli,Richard Kirsch,Yoichi Ajioka,Fred T. Bosman,Gieri Cathomas,Heather Dawson,Hala El Zimaity,Jean François Fléjou,Tine Plato Hansen,Arndt Hartmann,Sanjay Kakar,Cord Langner,Iris D. Nagtegaal,Giacomo Puppa,Robert H. Riddell,Ari Ristimäki,Kieran Sheahan,Thomas C. Smyrk,Kenichi Sugihara,Benoit Terris,Hideki Ueno,Michael Vieth,Inti Zlobec,Phil Quirke +23 more
TL;DR: Members of the ITBCC were able to reach strong consensus on a single international, evidence-based method for tumor budding assessment and reporting and it is proposed that this method be incorporated into colorectal cancer guidelines/protocols and staging systems.
Journal ArticleDOI
Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis
Andrew G Renehan,Lee Malcomson,Richard Emsley,Simon Gollins,Andrew Maw,Arthur Sun Myint,Paul S Rooney,Shabbir Susnerwala,Anthony Blower,Mark P Saunders,Malcolm S Wilson,Nigel Scott,Sarah T O'Dwyer +12 more
TL;DR: Comparing oncological outcomes between patients managed by watch and wait who achieved a clinical complete response and those who had surgical resection to address the shortage of evidence regarding the safety of the watch-and-wait approach is addressed.
Journal ArticleDOI
The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges.
Zhenyu Liu,Shuo Wang,Di Dong,Jingwei Wei,Cheng Fang,Xuezhi Zhou,Kai Sun,Longfei Li,Bo Li,Meiyun Wang,Jie Tian,Jie Tian +11 more
TL;DR: The recent methodological developments in radiomics are reviewed, including data acquisition, tumor segmentation, feature extraction, and modelling, as well as the rapidly developing deep learning technology.
Journal ArticleDOI
Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Zhenyu Liu,Xiao-Yan Zhang,Yan-Jie Shi,Lin Wang,Hai-Tao Zhu,Zhenchao Tang,Shuo Wang,Xiao-Ting Li,Jie Tian,Ying-Shi Sun +9 more
TL;DR: Using pre- and posttreatment MRI data, a radiomics model with excellent performance for individualized, noninvasive prediction of pCR is developed and may be used to identify LARC patients who can omit surgery after chemoradiotherapy.
Journal ArticleDOI
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial
Yong Sang Hong,Byung-Ho Nam,Kyu Pyo Kim,Jeong Eun Kim,Seong Joon Park,Young Suk Park,Joon Oh Park,Sun-Young Kim,Tae You Kim,Jee Hyun Kim,Joong Bae Ahn,Seok Byung Lim,Chang Sik Yu,Jin Cheon Kim,Seong Hyeon Yun,Jong Hoon Kim,Jin-Hong Park,Hee Chul Park,Kyung Hae Jung,Tae Won Kim +19 more
TL;DR: This open-label, multicentre, phase 2, randomised trial aimed to compare the efficacy and safety of adjuvant fluorouracil and leucovorin with that of FOLFOX in patients with locally advanced rectal cancer after preoperative chemoradiotherapy.
References
More filters
Journal ArticleDOI
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Rolf Sauer,Heinz Becker,Werner Hohenberger,Claus Rödel,Christian Wittekind,Rainer Fietkau,Peter Martus,Jörg Tschmelitsch,Eva Hager,Clemens F. Hess,Torsten Liersch,Heinz Schmidberger,Rudolf Raab +12 more
TL;DR: Preoperative chemoradiotherapy, as compared with postoperative cheMoradi therapy, improved local control and was associated with reduced toxicity but did not improve overall survival.
Journal ArticleDOI
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay,Eva Steliarova-Foucher,Joannie Lortet-Tieulent,Sonia Rosso,Jan Willem Coebergh,Harry Comber,David Forman,Freddie Bray +7 more
TL;DR: Up-to-date estimates of the cancer burden in Europe alongside the description of the varying distribution of common cancers at both the regional and country level provide a basis for establishing priorities to cancer control actions in Europe.
Journal ArticleDOI
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Ellen Kapiteijn,Corrie A.M. Marijnen,Iris D. Nagtegaal,Hein Putter,W.H. Steup,Theo Wiggers,Harm J. T. Rutten,Lars Påhlman,Bengt Glimelius,J. Han van Krieken,J.W.H. Leer,Cornelis J.H. van de Velde +11 more
TL;DR: In this article, the authors conducted a multicenter, randomized trial to determine whether the addition of preoperative radiotherapy increases the benefit of total mesorectal excision, and the overall rate of survival at two years among the eligible patients was 82.0 percent in the group assigned to both radiotherapy and surgery.
Journal ArticleDOI
The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?
TL;DR: Five cases are described where minute foci of adenocarcinoma have been demonstrated in the mesorectum several centimetres distal to the apparent lower edge of a rectal cancer, and these operations have been carried out as a part of over 100 consecutive anterior resections.
Journal ArticleDOI
Chemotherapy with preoperative radiotherapy in rectal cancer
Jean-François Bosset,Laurence Collette,Gilles Calais,Laurent Mineur,Philippe Maingon,L. Radosevic-Jelic,Alain Daban,Etienne Bardet,Alexander Beny,Jean-Claude Ollier +9 more
TL;DR: In patients with rectal cancer who receive preoperative radiotherapy, adding fluorouracil-based chemotherapy preoperatively or postoperatively has no significant effect on survival.
Related Papers (5)
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
Toshiaki Watanabe,Michio Itabashi,Yasuhiro Shimada,Shinji Tanaka,Yoshinori Ito,Yoichi Ajioka,Tetsuya Hamaguchi,Ichinosuke Hyodo,Masahiro Igarashi,Hideyuki Ishida,Megumi Ishiguro,Yukihide Kanemitsu,Norihiro Kokudo,Kei Muro,Atsushi Ochiai,Masahiko Oguchi,Yasuo Ohkura,Yutaka Saito,Yoshiharu Sakai,Hideki Ueno,Takayuki Yoshino,Takahiro Fujimori,Nobuo Koinuma,Takayuki Morita,Genichi Nishimura,Yuh Sakata,Keiichi Takahashi,Hiroya Takiuchi,Osamu Tsuruta,Toshiharu Yamaguchi,Masahiro Yoshida,Naohiko Yamaguchi,Kenjiro Kotake,Kenichi Sugihara,Rectum +34 more